Het rapport
Geverifieerd nieuws over financiering, hoofdkantoren en leiderschap van 's werelds meest innovatieve bedrijven
109 rapporten en meer
Verisave Appoints Chris Lefebvre Chief Executive Officer
Verisave appointed Chris Lefebvre, who joins from Fiserv, as CEO to drive product development and growth, succeeding Jeremy Layton, who moves to Founder and Chief Commercial Officer.
AngioDynamics Appoints Eric Honroth President and Chief Executive Officer
AngioDynamics announced that Eric Honroth, who most recently served as Global President, Life Science at Getinge, will become President and CEO on November 2, 2026, succeeding Jim Clemmer, who is retiring after ten years in the role.
Marwood Group Appoints Chris Librizzi Chief Executive Officer
Marwood Group named former EY-Parthenon executive Chris Librizzi CEO alongside a strategic investment from funds managed by Lee Equity Partners that will support continued growth, including acquisitions and senior team hires.
IQSIGHT Appoints Michael J. Schulte Chief Executive Officer
IQSIGHT appointed Michael J. Schulte, most recently of Clarience Technologies, as CEO to lead the video security company’s next phase of growth under Chairman Steve Shine.
Choice Hotels Appoints Dominic Dragisich President and Chief Executive Officer
Choice Hotels’ Board appointed Interim CEO Dominic Dragisich as President and Chief Executive Officer and a director, with a focus on disciplined execution and growth.
Barchemy Appoints Isaac Long Chief Executive Officer
Barchemy announced the appointment of food industry executive Isaac Long as Chief Executive Officer, succeeding founder Larry Toscano, who will become Chairman.
Cadara Appoints Marina Aslanyan Chief Executive Officer
Cadara, formerly National Care Systems, appointed former SmartLinx CEO Marina Aslanyan to lead the post-acute care technology company’s strategy, product innovation, customer success, and commercial growth.
IDnow Appoints Philippe Morel as Chief Executive Officer
IDnow appointed former Railsr and SETL CEO Philippe Morel, who succeeds Andreas Bodczek, as Chief Executive Officer of the digital identity and fraud prevention company.
Idorsia Appoints Roland Wandeler Chief Executive Officer
Idorsia appointed Grifols Biopharma president Roland Wandeler CEO, succeeding ad-interim CEO Jean-Paul Clozel, to lead the company’s next phase of growth.
Tonen van 9 rapporten • Pagina 1 • Categorie: all
Loop voor op de markt
Ontvang wekelijkse inzichten in uw inbox. Geen spam, alleen intelligentie.